Teva to host the conference conference to discuss from the first quarter 2025 financial results at 8:00 et on May 7, 2025

Tel Aviv, Israel, March 27, 2025 (Globe Newswire) – Teva Pharmaceutical Industries Ltd (Nyse and Tase: Teva) announced today that it will issue a press release in the first quarter 2025 Financial results on Wednesday, May 7, 2025, at 7:00 AM. Following the launch, Teva will make a conference call and a live web transmission on the same day, at 8:00 am et.

To participate, please register in advance Here To get a local or no phone number and personal PIN.

A live call web transmission will be available on the Teva site at: https://ir.tevapharm.com/events-and-predentations.

After the call is concluded, a playcast playback will be available in 24 hours on the Teva site.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and Tase: Teva) is another type of global biopharmaceutical leader, one that operates over the entire innovation spectrum to deliver drugs to patients around the world. For over 120 years, Teva’s commitment to improve health has never decreased. Today, the global company’s capacity network allows the 37,000 employees on 57 markets to advance health by developing medicines for the future, while promoting the production of generic and biological. We are dedicated to respond to patients’ needs now and in the future. Going further with the treatment that treats, inspired by the people we serve. To find out more about how Teva is for better health, visit www.tevapharm.com.

Precaution note on prospective statements

This press release and the conference call may contain prospective statements within the meaning of the private law of private private disputes of 1995, which are based on the current beliefs and expectations of the management and are subject to the risks and uncertainties, both known and unknown, which could determine our future results, or looking at advantageous. Important factors that could cause or contribute to such differences include risks related to: our ability to successfully compete on the market, including our ability to successfully execute our pivot to the growth strategy; our significant indebtedness; our business and operations in general; Problems of compliance, regulations and disputes; other financial and economic risks; And other factors discussed in this press release, in our annual report on form 10-K for the year ended on December 31, 2024, including in the sections of the “Risk Factors” and “Prospective Statements”. Prospective statements speak only from the date on which they are made and we do not assume any obligation to update or review any prospective statements or other information contained here, either as a result of new information, future or other events. You are warned not to make an unjustified addiction to these prospective statements.